Dynamic Ca2+ signalling in rat arterial smooth muscle cells under the control of local renin‐angiotensin system

1 We visualized the changes in intracellular Ca2+ concentration ([Ca2+]i), using fluo‐3 as an indicator, in individual smooth muscle cells within intact rat tail artery preparations. 2 On average in about 45 % of the vascular smooth muscle cells we found spontaneous Ca2+ waves and oscillations (≈0.13 Hz), which we refer to here as Ca2+ ripples because the peak amplitude of [Ca2+]i was about one‐seventh of that of Ca2+ oscillations evoked by noradrenaline. 3 We also found another pattern of spontaneous Ca2+ transients often in groups of two to three cells. They were rarely observed and are referred to as Ca2+ flashes because their peak amplitude was nearly twice as large as that in noradrenaline‐evoked responses. 4 Sympathetic nerve activity was not considered responsible for the Ca2+ ripples, and they were abolished by inhibitors of either the Ca2+ pump in the sarcoplasmic reticulum (cyclopiazonic acid) or phospholipase C (U‐73122). 5 Both angiotensin antagonists ([Sar1,Ile8]‐angiotensin II and losartan) and an angiotensin converting enzyme inhibitor (captopril) inhibited the Ca2+ ripples. 6 The extracellular Ca2+‐dependent tension borne by unstimulated arterial rings was reduced by the angiotensin antagonist by ≈50 %. 7 These results indicate that the Ca2+ ripples are generated via inositol 1,4,5‐trisphosphate‐induced Ca2+ release from the intracellular Ca2+ stores in response to locally produced angiotensin II, which contributes to the maintenance of vascular tone.

[1]  A. Samarel,et al.  Calcium- and protein kinase C-dependent activation of the tyrosine kinase PYK2 by angiotensin II in vascular smooth muscle. , 1998, Circulation research.

[2]  L. Graves,et al.  Regulation of a Calcium-dependent Tyrosine Kinase in Vascular Smooth Muscle Cells by Angiotensin II and Platelet-derived Growth Factor , 1998, The Journal of Biological Chemistry.

[3]  Y. Taketani,et al.  Endothelium‐dependent frequency modulation of Ca2+ signalling in individual vascular smooth muscle cells of the rat , 1997, The Journal of physiology.

[4]  H. Ozaki,et al.  Cytochalasin D inhibits smooth muscle contraction by directly inhibiting contractile apparatus. , 1996, Journal of smooth muscle research = Nihon Heikatsukin Gakkai kikanshi.

[5]  M. Rubart,et al.  Relaxation of Arterial Smooth Muscle by Calcium Sparks , 1995, Science.

[6]  H. Kasai,et al.  Visualization of neural control of intracellular Ca2+ concentration in single vascular smooth muscle cells in situ. , 1994, The EMBO journal.

[7]  M. Endo,et al.  Effects of cyclopiazonic acid on rhythmic contractions in uterine smooth muscle bundles of the rat , 1994, British journal of pharmacology.

[8]  H. Itoh,et al.  Multiple autocrine growth factors modulate vascular smooth muscle cell growth response to angiotensin II. , 1993, The Journal of clinical investigation.

[9]  V. Dzau Tissue renin-angiotensin system in myocardial hypertrophy and failure. , 1993, Archives of internal medicine.

[10]  M. Berridge Inositol trisphosphate and calcium signalling , 1993, Nature.

[11]  A. Doherty,et al.  Design of a functional hexapeptide antagonist of endothelin. , 1992, Journal of medicinal chemistry.

[12]  I. Takahashi,et al.  Wortmannin, a microbial product inhibitor of myosin light chain kinase. , 1992, The Journal of biological chemistry.

[13]  M. Daemen,et al.  Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall. , 1991, Circulation research.

[14]  J. Madri,et al.  Influence of the angiotensin system on endothelial and smooth muscle cell migration. , 1990, The American journal of pathology.

[15]  R. Smith,et al.  Receptor-coupled signal transduction in human polymorphonuclear neutrophils: effects of a novel inhibitor of phospholipase C-dependent processes on cell responsiveness. , 1990, The Journal of pharmacology and experimental therapeutics.

[16]  F. Edwards,et al.  Sympathetic neuroeffector transmission in arteries and arterioles. , 1989, Physiological reviews.

[17]  R. J. Cole,et al.  Cyclopiazonic acid inhibition of the Ca2+-transport ATPase in rat skeletal muscle sarcoplasmic reticulum vesicles. , 1988, Biochemical pharmacology.

[18]  J. Wood,et al.  Effects of a specific and long-acting renin inhibitor in the marmoset. , 1985, Hypertension.

[19]  H. Suzuki,et al.  Electrical property and chemical sensitivity of vascular smooth muscles in normotensive and spontaneously hypersensitive rats. , 1978, The Journal of physiology.

[20]  M. Peach Renin-angiotensin system: biochemistry and mechanisms of action. , 1977, Physiological reviews.

[21]  C. Sweet,et al.  A New, Long-Lasting Competitive Inhibitor of Angiotensin , 1972, Science.

[22]  B. Zimmerman,et al.  Tissue renin-angiotensin system: a site of drug action? , 1997, Annual review of pharmacology and toxicology.

[23]  G. Booz,et al.  Cardiac actions of angiotensin II: Role of an intracardiac renin-angiotensin system. , 1992, Annual review of physiology.